Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
Covidien's Pipeline aneurysm device shows 8.5% major complication rate in early post-market results. Surprise at long-term results for endovascular repair of abdominal aortic aneurysms. More clinical trial news.
You may also be interested in...
Medtronic Reveals Plans For Next-Generation ‘Drug-Filled’ Stent
The firm characterizes the early-stage technology as its answer to Abbott’s bioabsorbable vascular scaffold and Boston Scientific’s bioabsorbable polymer coronary stents.
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
Draft rules are still being developed to fully implement ClinicalTrials.gov, but the law has been in effect for some time and officials say they are making a consistent effort to ensure study sponsors are educated on their new responsibilities.
New Products In Brief
Covidien’s Pipeline gains PMA approval